An epigenomic approach to therapy for tamoxifen-resistant breast cancer

Tamoxifen has been a frontline treatment for estrogen receptor alpha (ERα)-positive breast tumors in premenopausal women. However, resistance to tamoxifen occurs in many patients. ER still plays a critical role in the growth of breast cancer cells with acquired tamoxifen resistance, suggesting that...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Qin, Zhang, Zheng, Shea, Martin J, Creighton, Chad J, Coarfa, Cristian, Hilsenbeck, Susan G, Lanz, Rainer, He, Bin, Wang, Lei, Fu, Xiaoyong, Nardone, Agostina, Song, Yongcheng, Bradner, James, Mitsiades, Nicholas, Mitsiades, Constantine S, Osborne, C Kent, Schiff, Rachel, O'Malley, Bert W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085766/
https://www.ncbi.nlm.nih.gov/pubmed/24874954
http://dx.doi.org/10.1038/cr.2014.71

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085766/
https://www.ncbi.nlm.nih.gov/pubmed/24874954
http://dx.doi.org/10.1038/cr.2014.71

Ejemplares similares